David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Universal Display
OLED
$4.11B
| $1.3M | ﹤0.01% |
24,097
-93,730
| -80% | -$4.58M |
|
|
RAD
2152
CALL
DELISTED
Rite Aid Corporation
RAD
| $1.3M | ﹤0.01% |
8,000
-12,500
| -61% | -$1.97M |
|
|
DTLK
2153
DELISTED
Datalink Corp
DTLK
| $1.3M | ﹤0.01% |
142,658
-48,116
| -25% | -$348K |
|
2154
First Financial Bankshares
FFIN
$4.83B
| $1.29M | ﹤0.01% |
87,494
-66,508
| -43% | -$913K |
|
|
TNGO
2155
DELISTED
Tangoe, Inc.
TNGO
| $1.29M | ﹤0.01% |
163,446
+16,202
| +11% | +$127K |
|
2156
HNI Corp
HNI
$3.6B
| $1.28M | ﹤0.01% |
32,781
+6,433
| +24% | +$219K |
|
|
ELOS
2157
DELISTED
Syneron Medical Ltd
ELOS
| $1.28M | ﹤0.01% |
175,458
-14,523
| -8% | -$104K |
|
|
LLL
2158
DELISTED
L3 Technologies, Inc.
LLL
| $1.28M | ﹤0.01% |
+10,782
| New | +$1.26M |
|
|
DNB
2159
CALL
DELISTED
Dun & Bradstreet
DNB
| $1.28M | ﹤0.01% |
12,400
| – | – |
|
2160
PUT
Ionis Pharmaceuticals
IONS
$10.6B
| $1.28M | ﹤0.01% |
31,500
+22,100
| +235% | +$898K |
|
2161
PUT
State Street
STT
$53B
| $1.28M | ﹤0.01% |
+21,800
| New | +$1.24M |
|
|
NAV
2162
DELISTED
Navistar International
NAV
| $1.28M | ﹤0.01% |
101,887
-217,165
| -68% | -$1.98M |
|
|
OKSB
2163
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $1.28M | ﹤0.01% |
84,796
+5,844
| +7% | +$92K |
|
2164
Capitol Federal Financial
CFFN
$1.05B
| $1.27M | ﹤0.01% |
96,124
+32,795
| +52% | +$409K |
|
2165
CALL
Duke Energy
DUK
$94.8B
| $1.27M | ﹤0.01% |
15,800
-31,200
| -66% | -$2.36M |
|
|
RDC
2166
PUT
DELISTED
Rowan Companies Plc
RDC
| $1.27M | ﹤0.01% |
79,100
-93,200
| -54% | -$1.29M |
|
|
EXAR
2167
DELISTED
Exar Corporation
EXAR
| $1.27M | ﹤0.01% |
221,186
+84,099
| +61% | +$454K |
|
2168
PUT
CACI
CACI
$13.5B
| $1.27M | ﹤0.01% |
11,900
| – | – |
|
2169
PUT
Voya Financial
VOYA
$9.11B
| $1.27M | ﹤0.01% |
+42,600
| New | +$1.29M |
|
|
UPL
2170
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $1.27M | ﹤0.01% |
+2,545,873
| New | +$3.01M |
|
2171
Xencor
XNCR
$2.18B
| $1.27M | ﹤0.01% |
94,411
+9,168
| +11% | +$108K |
|
2172
Commercial Metals
CMC
$7.4B
| $1.26M | ﹤0.01% |
74,570
-52,720
| -41% | -$773K |
|
2173
REX American Resources
REX
$1.37B
| $1.26M | ﹤0.01% |
136,884
+70,284
| +106% | +$606K |
|
|
ESI
2174
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $1.26M | ﹤0.01% |
409,505
+207,263
| +102% | +$603K |
|
2175
Future Fuel
FF
$236M
| $1.26M | ﹤0.01% |
107,153
+37,452
| +54% | +$458K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.